Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

ICOS+ Th cells produce distinct cytokines in different mucosal immune responses.

Bonhagen K, Liesenfeld O, Stadecker MJ, Hutloff A, Erb K, Coyle AJ, Lipp M, Kroczek RA, Kamradt T.

Eur J Immunol. 2003 Feb;33(2):392-401.

2.

ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.

Khayyamian S, Hutloff A, Büchner K, Gräfe M, Henn V, Kroczek RA, Mages HW.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6198-203.

3.

ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses.

Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos JC, Coyle AJ.

Nat Immunol. 2001 Jul;2(7):597-604.

PMID:
11429543
4.

B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses.

Wilson EH, Zaph C, Mohrs M, Welcher A, Siu J, Artis D, Hunter CA.

J Immunol. 2006 Aug 15;177(4):2365-72.

5.

Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection.

Kropf P, Bickle Q, Herath S, Klemenz R, Müller I.

Eur J Immunol. 2002 Sep;32(9):2450-9.

6.

Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.

Yagi J, Arimura Y, Dianzani U, Uede T, Okamoto T, Uchiyama T.

J Immunol. 2003 Jul 15;171(2):783-94.

7.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A.

J Neuroimmunol. 2003 Jul;140(1-2):177-87.

PMID:
12864987
8.

The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo.

Akiba H, Takeda K, Kojima Y, Usui Y, Harada N, Yamazaki T, Ma J, Tezuka K, Yagita H, Okumura K.

J Immunol. 2005 Aug 15;175(4):2340-8.

9.

Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ.

J Immunol. 2000 Nov 1;165(9):5035-40.

10.

Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation.

Wiley RE, Goncharova S, Shea T, Johnson JR, Coyle AJ, Jordana M.

Am J Respir Cell Mol Biol. 2003 Jun;28(6):722-30.

PMID:
12760969
12.
13.

Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.

Löhning M, Hutloff A, Kallinich T, Mages HW, Bonhagen K, Radbruch A, Hamelmann E, Kroczek RA.

J Exp Med. 2003 Jan 20;197(2):181-93.

14.
15.
16.

ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells.

Wassink L, Vieira PL, Smits HH, Kingsbury GA, Coyle AJ, Kapsenberg ML, Wierenga EA.

J Immunol. 2004 Aug 1;173(3):1779-86.

17.

A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.

Arimura Y, Kato H, Dianzani U, Okamoto T, Kamekura S, Buonfiglio D, Miyoshi-Akiyama T, Uchiyama T, Yagi J.

Int Immunol. 2002 Jun;14(6):555-66.

PMID:
12039907
19.
20.

ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.

Watanabe M, Watanabe S, Hara Y, Harada Y, Kubo M, Tanabe K, Toma H, Abe R.

J Immunol. 2005 Feb 15;174(4):1989-96.

Supplemental Content

Support Center